EUVIMEDEUVIMED entdecken
Crossref

Identification of Honokiol‐Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies

Simone Di Micco, Dafne Ruggiero, Stefania Terracciano, Ines Bruno, Nunzio Cardullo, Vera Muccilli, Corrado Tringali, Giuseppe Bifulco

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202401854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Simone Di Micco und 7 weiteren Autor:innen. Beteiligte Einrichtung: European Biomedical Research Institute of Salerno (EBRIS), Via Salvatore De Renzi 50, 84125, Salerno, Italy. Hauptthemen laut MEDLINE: Lignans, Tankyrases, Biphenyl Compounds, Enzyme Inhibitors. Die Arbeit nennt 59 Literaturangaben. Gefördert von: Ministero dell'Università e della Ricerca (MUR)-PRIN2022-PNRR project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, we identified magnolol bioinspired derivatives as new Tankyrase 1/2 (TNKS1/2) inhibitors by our Inverse Virtual Screening protocol. Based on these findings, in the present contribution, we enlarged our investigation of neolignans to the natural product honokiol ( 1 ) and a group of its analogues ( 2 – 8 ). By integrating in silico analysis and Surface Plasmon Resonance experiments, we investigated the binding of tested compounds against biological target under investigations. Specifically, 1 (honokiol), 2 , 6 and 7 bound TNKS2 with a K D in the low nanomolar range, whereas 3 – 5 and 8 showed absence of affinity for the macromolecule. Furthermore, we also proved the binding specificity of 1 and 7 against TNKS2, while 2 and 6 were found to be also TNKS1 binders. The congener 4 was identified as specific TNKS1 ligand. Promising antiproliferative activity in A549 cancer cell line were obtained for 1 and 6 , with honokiol ( 1 ) presenting a higher potency than the well‐known TNKS2 inhibitor XAV939. Collectively, these outcomes suggest that the honokiol‐based scaffold can be employed to design novel anti‐cancer therapeutic agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansTankyrasesBiphenyl CompoundsEnzyme InhibitorsCell ProliferationDrug DesignHumansStructure-Activity RelationshipMolecular StructureDrug Screening Assays, AntitumorDose-Response Relationship, DrugAntineoplastic AgentsA549 CellsAllyl CompoundsPhenols

Stichwörter der Autor:innen

Anti-cancer drugsBioinspired compoundsCasein kinase 2 inhibitorsTankyrase 1 inhibitorsTankyrase 2 inhibitors

Substanzen

LignansTankyraseshonokiolBiphenyl CompoundsEnzyme InhibitorsTNKS2 protein, humanTNKS protein, humanAntineoplastic AgentsAllyl CompoundsPhenols

Autor:innen und Institutionen

  • European Biomedical Research Institute of Salerno (EBRIS), Via Salvatore De Renzi 50, 84125, Salerno, Italy.
  • Department of Pharmacy, University of Salerno, Via Giovanni Paolo II 132, 84084, Fisciano (SA), Italy.
  • Department of Chemical Sciences, University of Catania, Viale A. Doria 6, 95125, Catania, Italy.

Förderung

  • Ministero dell'Università e della Ricerca (MUR)-PRIN2022-PNRR project

Zitieren

APA

Di Micco, S., Ruggiero, D., Terracciano, S., Bruno, I., Cardullo, N., Muccilli, V., Tringali, C., & Bifulco, G. (2025). Identification of Honokiol‐Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202401854

Vancouver

Di Micco S, Ruggiero D, Terracciano S, Bruno I, Cardullo N, Muccilli V, et al. Identification of Honokiol‐Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202401854

BibTeX
@article{DiMicco2025,
  author = {Di Micco, Simone and Ruggiero, Dafne and Terracciano, Stefania and Bruno, Ines and Cardullo, Nunzio and Muccilli, Vera and Tringali, Corrado and Bifulco, Giuseppe},
  title = {Identification of Honokiol‐Based Scaffold to Design Tankyrase 1/2 Inhibitors by In Silico and In Vitro Studies},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202401854}
}
Kostenlos starten →